Where this topic shows up
Our markets on gut health, by category.
- OTC & Nutraceuticals · 4
- Pharmaceuticals · 2
Market reports
Worldwide reports first. Each covers 2024 history, a 2025 base year and forecasts to 2034.
OTC & Nutraceuticals
Anthelmintic Drug
Worldwide · 2024–2034
View report PharmaceuticalsGastroesophageal Reflux Disease (GERD) Drugs
Worldwide · 2024–2034
View report PharmaceuticalsGastrointestinal Drugs
Worldwide · 2024–2034
View report OTC & NutraceuticalsOver The Counter (OTC) Gastrointestinal Drugs
Worldwide · 2024–2034
View report OTC & NutraceuticalsPrebiotics
Worldwide · 2024–2034
View report OTC & NutraceuticalsProbiotic Supplements for Gut Health
Worldwide · 2024–2034
View reportKey companies
Named as key players in the most of these markets.
Bayer AG3 markets here
GSK PLC2 markets here
Sanofi2 markets here
Yakult Honsha Co Ltd2 markets here
AbbVie Inc.1 market here
ADM1 market here
Amneal Pharmaceuticals, Inc1 market here
Archer-Daniels-Midland Company1 market here
AstraZeneca1 market here
Bausch Health1 market here
BioGaia1 market here
Boehringer Ingelheim International GmbH1 market here
All markets on this topic
Each opens the market's statistics page, with every country we cover.
OTC & Nutraceuticals
- Anthelmintic Drug
- Over The Counter (OTC) Gastrointestinal Drugs
- Prebiotics
- Probiotic Supplements for Gut Health
Pharmaceuticals
Related topics
Need research on gut health?
Full reports carry researched sizes, forecasts and company profiles. We also build custom studies.
Acuitas market figures are supplied with each full report. Chart data comes from the public sources named on each chart.